Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
IgD myeloma is an infrequent type of multiple myeloma and is characterized by an aggressive clinical behavior and a short survival time. No satisfactory treatments have thus far been established. Recently we treated a patient with IgD(lambda)-type myeloma with glucocorticoids, and succeeded in achieving a complete remission. This case seems to indicate a usefulness of glucocorticoid monotherapy for treating IgD myeloma.
Takemori
N
N
Department of Internal Medicine, J.A. Asahikawa Kosei Hospital, Japan. n.takemori@i.bekkoame.ne.jp
Kondo
K
K
Kawamura
T
T
Imai
K
K
Sakurai
H
H
Sato
T
T
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007072:Immunoglobulin D / Q000097:blood*; D007146:Immunoglobulin lambda-Chains / Q000097:blood*; D007372:Interferons / Q000627:therapeutic use; D008558:Melphalan / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy*; D009194:Myeloma Proteins / Q000032:analysis*; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D005938:Glucocorticoids; D007072:Immunoglobulin D; D007146:Immunoglobulin lambda-Chains; D009194:Myeloma Proteins; D009607:Nitrosourea Compounds; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D007372:Interferons; D011239:Prednisolone; D008558:Melphalan; C020766:ranimustine; D008775:Methylprednisolone